4593 — Healios KK Share News
0.000.00%
Last trade - 00:00Table: Healios -Q1 group results (IFRS)
Table: Healios -2025 parent results
Table: Healios -2025 group results (IFRS)
Table: Healios -2025 group forecast(IFRS)
Table: Healios -2025 parent forecast
Table: Healios -9-MTH group results (IFRS)
Table: Healios 6-MTH group results (IFRS)
Table: Healios -Q1 group results (IFRS)
Table: Healios -2024 parent results
Table: Healios -2024 group results (IFRS)
Table: Healios -2024 parent forecast
Table: Healios -2024 group forecast(IFRS)
Table: Healios -9-MTH group results (IFRS)
Cencora rises on $4.6 bln deal to buy Retina Consultants of America, Q4 profit beat
Brief: Healios Kk License Agreement With Astellas Pharma Concerning Rpe Cell Production Method
Table: Healios -Q1 group results (IFRS)
Table: Healios -2023 group results (IFRS)
Table: Healios -2023 parent results
Table: Healios -9-MTH group results (IFRS)